top of page

INOLYSIS – ADVANCED LEADS FOR FIBROSIS

TARGETING FIBROBLASTS TO COMBAT CHRONIC INFLAMMATORY AND FIBROTIC DISEASES

More than 50 million people worldwide are affected by chronic fibrotic diseases.

$75 billion per year is spent on managing healthcare expenses linked to fibrotic complications.

Over 20% of cancer patients face treatment challenges due to underlying fibrotic tissue changes.

Collaborators

OUR COLLABORATORS

Contact

CONTACT US

17 Trapezountos & Andrea Papandreou, 

Melissia 15127, Greece
Email: admin@inolysis.com

© 2025 INOLYSIS. All rights reserved.

bottom of page